- for the treatment of adult patients with relapsed or refractory cHL
- for the treatment of pediatric patients with refractory cHL, or cHL that has relapsed following ≥2 lines of therapy
### Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- for the treatment of adult and pediatric patients with refractory PMBCL, or PMBCL that has relapsed following ≥2 lines of therapy
### Urothelial Carcinoma
- for the treatment of locally advanced or metastatic urothelial carcinoma in patients ineligible for platinum-based chemotherapy
- for the treatment of locally advanced or metastatic urothelial carcinoma in patients who have disease progression during or following platinum-based chemotherapy or within 12 months of adjuvant/neoadjuvant platinum-based chemotherapy
- for the treatment of [BCG vaccine]-unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors, who are not candidates for cystectomy
- for the treatment of locally advanced or metastatic urothelial carcinoma in combination with enfortumab vedotin in adult patients ineligible for platinum-based chemotherapy under the accelerated approval from the FDA
### Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient Cancer (dMMR)
- as a last-line therapy for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors that have progressed following prior treatment
- for the treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer
### Gastric Cancer
- in combination with [trastuzumab], fluoropyrimidine-, and platinum-containing chemotherapy, as a first-line treatment for patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors express PD -L1 (CPS ≥1) as determined by an FDA-approved test
- in combination with fluoropyrimidine - and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
### Esophageal Cancer
- in combination with fluoropyrimidine- and platinum-based chemotherapy for the treatment of patients with locally advanced or metastatic esophageal or GEJ carcinoma who are not candidates for surgery or definitive chemoradiation
- as a monotherapy for the treatment of locally advanced or metastatic esophageal or GEJ carcinoma expressing PD-L1 in patients who are not candidates for surgery or definitive chemoradiation
### Cervical Cancer
- in combination with other chemotherapies, with or without [bevacizumab], for the treatment of persistent, recurrent, or metastatic cervical cancer expressing PD-L1
- as a monotherapy for the treatment of recurrent or metastatic cervical cancer expressing PD-L1 in patients who have experienced disease progression on or after previous chemotherapy
- in combination with chemoradiotherapy for the treatment of patients with FIGO 2014 Stage III -IVA cervical cancer
### Hepatocellular Carcinoma (HCC)
- as a monotherapy for the treatment of HCC in patients who have been previously treated with [sorafenib]
### Biliary Tract Cancer (BTC)
- in combination with [gemcitabine] and [cisplatin] for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer
### Merkel Cell Carcinoma (MCC)
- for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic MCC
### Renal Cell Carcinoma (RCC)
- in combination with either [axitinib] or [lenvatinib] as a first-line treatment for adult patients with advanced RCC
- for the adjuvant treatment of patients with RCC who are at an intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
### Endometrial Carcinoma
- in combination with carboplatin and paclitaxel, followed by pembrolizumab as a single agent, for the t reatment of adult patients with primary advanced or recurrent endometrial carcinoma
- in combination with lenvatinib for the treatment of patients with advanced endometrial carcinoma that is not MSI-H or dMMR who experience disease progression following prior systemic therapy and who are not candidates for surgery or radiation therapy
- as a monotherapy for the treatment of patients with advanced endometrial carcinoma that is MSI-H or dMMR who have disease progression following prior systemic therapy and are not candidates for curative surgery or radiation
### Tumor Mutational Burden-High (TMB-H) Cancer
- as a last-line therapy for the treatment of adult and pediatric patients with unresectable or metastatic TMB-H solid tumors that have progressed following prior treatment
### Cutaneous Squamous Cell Carcinoma (cSCC)
- for the treatment of patients with recurrent or metastatic sCC, or locally advanced sCC that is not curable with surgery or radiation therapy
### Triple-Negative Breast Cancer (TNBC)
- for the treatment of patients with high-risk early-stage TNBC, in combination with chemotherapy as a neoadjuvant treatment followed by continued use as a single adjuvant agent following surgery
- in combination with chemotherapy for the treatment of locally recurrent unresectable or metastatic TNBC expressing PD-L1
For all approved adult indications, pembrolizumab may be used for an additional 6 weeks at 400mg weekly.[L38934]', '', '', 6148, '2022-08-05', CURRENT_TIMESTAMP),
(5847, 'Grozax 3000 unit syrup 70 ml', 'جروزاكس 3000 وحدة شراب 70 مل', '', '75', 'Alpha amylase', 'Hoffmann pharm', 'Syrup', 'شراب', '', 'Anti edematous', '3000 unit', '', '', '', 989, '2025-07-11', CURRENT_TIMESTAMP),
(28007, 'Tenaloswab 1% cream 30 gm', 'تينالوسواب 1% كريم 30جم', '28.8', '52', 'Butenafine hydrochloride', 'Uniswab', 'Cream', 'كريم', '', 'Antifungals.allylamines', '1%', 'For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to <i>M. furfur</i>, interdigital tinea pedis (athlete&rsquo;s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to <i>E. floccosum</i>, <i>T. mentagrophytes</i>, <i>T. rubrum</i>, and <i>T. tonsurans</i>.', '6224008379133', '', 998, '2024-02-18', CURRENT_TIMESTAMP),
(26402, 'Rupatoclear 10 mg 20 tabs.', 'روباتوكلير 10مجم 10 قرص', '34', '76', 'Rupatadine', 'Horus for pharmaceutical products', 'Tab', 'أقراص', '', 'Antihistamine.second-generation', '10 mg', 'For the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and perennial allergic rhinitis in patients 2 years of age and older [FDA Label]. Also used for the symptomatic relief of chronic spontaneous urticaria in patients 2 years of age and older.', '', '', 888, '2024-12-25', CURRENT_TIMESTAMP),
(25772, 'Recormon 4000 i.u. 6 pref. syringes', 'ريكورمون 4000وحدة دولية 6 سرنجات معبأة للحقن', '1338', '2,131', 'Erythropoietin-beta', 'F.hoffman la roche > hoffmann la-roche ltd', 'Syringe', 'حقنة', 'امبولات تستخدم كمعوض للحديد -- الحفاظ علي نسبة الهيموجلوبين بالجسم ---يستخدم في حالات فقد دم بكمية كبيرة', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', '', 'about epoetin beta synthetic recombinant form of erythropoietin erythropoiesis stimulant antianaemic. mechanism of action of epoetin beta erythropoietin regulates erythropoiesis by stimulating the differentiation and proliferation of erythroid precursors', '', '', 15619, '2024-11-08', CURRENT_TIMESTAMP),
(2615, 'Cipramax 40mg 30 f.c. tab.', 'سيبراماكس 40مجم 30 قرص', '150', '210', 'Citalopram', 'Bioriginal international group pharma egypt > copad pharma', 'Tab', 'أقراص', 'علاج للاكتئاب', 'Psychiatric.antidepressants', '40mg', 'Citalopram is approved by the FDA for treating adults with major depressive disorder.[L47941] It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.[L5224,A321,A322,A261296]', '6223011340291', '', 1418, '2025-09-15', CURRENT_TIMESTAMP),
(6061, 'معجون اسنان سيجنال وسط', 'سيجنال وسط معجون اسنان', '', '35', '', 'Company', 'Unknown', 'غير محدد', '', '', '', '', '6221048407796', '', 994, '2023-01-25', CURRENT_TIMESTAMP),
(7178, 'Legalex 70mg 40 tab.', 'ليجالكس 70مجم 40 قرص', '', '12', 'Silymarin', 'Alexandria', 'Tab', 'أقراص', 'مكمل غذائي للكبد.', 'Liver support supplements', '70mg', 'about silymarin a polyphenolic flavonoid hepatoprotective(antihepatotoxic) antioxidant. mechanism of action of silymarin silymarin stimulates rna polymerase a and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepa', '6223000176030', '', 1019, '2022-12-06', CURRENT_TIMESTAMP),
